Bridgeway Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
Other funds holding OYST
Bridgeway Capital Management's OYST Position: Q1 2023 in Review
Bridgeway Capital Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 40,000 shares — an estimated $447K sold.
Bridgeway Capital Management first reported a position in OYST in Q2 2022 and held it in 3 quarters. The position peaked at $447K in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.
- Bridgeway Capital Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Bridgeway Capital Management sold 40,000 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $447K.
- Bridgeway Capital Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
- Bridgeway Capital Management's Oyster Point Pharma, Inc. Common Stock position peaked at $447K in Q4 2022.
- 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.
Based on Bridgeway Capital Management's 13F filing for Q1 2023, filed 15 May 2023.